August 14, 2001

A pharmaceutical composition is provided containing an admixture of phenytoin sodium and an erodible matrix which extends the release of the phenytoin sodium over about a two hour period. The erodible matrix comprises binder(s) and diluent(s) which control the release of drug from the pharmaceutical composition. The erodible matrix can further comprise an alkaline pH modifier.

44

August 14, 2001

09/255,705

February 23, 1999

424/451   424/464 424/484 424/485 424/486 424/487 424/488 424/489 514/770 514/772.3 514/773 514/774 514/777 514/778 514/779 514/781 514/782 514/783

A61K   9/20   (20060101)   A61K   9/48   (20060101)  

424/468   424/484   424/457   424/488   424/485   424/486   424/487   424/489   424/451   424/464  

6620432 - Phenytoin sodium pharmaceutical compositions - Owned by Mylan Pharmaceuticals Inc. (Morgantown, WV) A pharmaceutical composition is provided containing an admixture of phenytoin sodium and an erodible matrix which extends the release of the phenytoin sodium over about a two hour period. The erodible matrix comprises binder(s) and diluent(s) which control the release of drug from the pharmaceutical composition. The erodible matrix can further comprise an alkaline pH modifier.